The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
LumaSon
Sulfur Hexafluoride · SULFUR HEXAFLUORIDE 60.7 mg/mg; DISTEAROYLPHOSPHATIDYLCHOLINE, DL- .19 mg/mg; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL) .19 mg/mg · Injection, Powder, Lyophilized, For Suspension · Intravenous; Intravesical · Bracco Diagnostics Inc
NDC 00270-7097-07 · 20 VIAL in 1 BOX / 25 mg in 1 VIAL · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicare Part B (ASP)
Payment limit per 1 ML
$18.126
HCPCS Q9950 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Airgas Therapeutics LlcUnited Statesapi manufacture
- Bracco Imaging SpaItalyanalysis · manufacture
- Bracco Suisse SASwitzerlandanalysis · manufacture
- Lipoid GmbHGermanyapi manufacture
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA203684
- TE code
- —
- Approval date
- Oct 15, 2014
- Patents / exclusivity
- 3 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11723869 | May 15, 2039 |
| patent | 10232061 | Jul 6, 2038 |
| patent | 10335502 | Jul 6, 2038 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sulfur Hexafluoride (Injection, Powder, Lyophilized, For Suspension)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bracco Diagnostics Inc | SULFUR HEXAFLUORIDE 60.7 mg/mg; DISTEAROYLPHOSPHATIDYLCHOLINE, DL- .19 mg/mg; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL) .19 mg/mg | Aug 26, 2026 | Aug 28, 2026 |
| Bracco Diagnostics Inc | SULFUR HEXAFLUORIDE .19 mg/mg; DISTEAROYLPHOSPHATIDYLCHOLINE, DL- .19 mg/mg; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL) 60.7 mg/mg | Jul 22, 2026 | Aug 22, 2026 |
| Bracco Diagnostics Inc | DISTEAROYLPHOSPHATIDYLCHOLINE, DL- .19 mg/mg; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL) .19 mg/mg; SULFUR HEXAFLUORIDE 60.7 mg/mg | Jul 15, 2026 | Jul 18, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "LumaSon — NDC 00270-7097-07," retrieved September 3, 2026, https://drugdashboards.com/drug/00270709707.
Free to cite with attribution — see how the data is put together.